Literature DB >> 20618334

A doctor(s) dilemma: ETV6-ABL1 positive acute lymphoblastic leukaemia.

Andrea Malone, Stephen Langabeer, Aengus O'Marcaigh, Lorna Storey, Christopher L Bacon, Owen P Smith.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20618334     DOI： 10.1111/j.1365-2141.2010.08323.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN： 0007-1048            Impact factor:   6.998


× No keyword cloud information.
  9 in total

Review 1.  Allosteric Inhibition of ABL Kinases: Therapeutic Potential in Cancer.

Authors:  Jill K Jones; Eric M Thompson
Journal:  Mol Cancer Ther       Date:  2020-06-30       Impact factor: 6.261

2.  ETV6-ABL1 fusion combined with monosomy 7 in childhood B-precursor acute lymphoblastic leukemia.

Authors:  Suguru Uemura; Noriyuki Nishimura; Daiichiro Hasegawa; Akemi Shono; Kimiyoshi Sakaguchi; Hisayuki Matsumoto; Yuji Nakamachi; Jun Saegusa; Takehito Yokoi; Teppei Tahara; Akihiro Tamura; Nobuyuki Yamamoto; Atsuro Saito; Aiko Kozaki; Kenji Kishimoto; Toshiaki Ishida; Nanako Nino; Satoru Takafuji; Takeshi Mori; Kazumoto Iijima; Yoshiyuki Kosaka
Journal:  Int J Hematol       Date:  2017-11-24       Impact factor: 2.490

3.  Cryptic ETV6-ABL1 Fusion and MLL2 Truncation Revealed by Integrative Clinical Sequencing in Multiply Relapsed Acute Lymphoblastic Leukemia.

Authors:  Nikhil P Mankuzhy; Emily Walling; Bailey Anderson; Rajen Mody
Journal:  J Pediatr Hematol Oncol       Date:  2019-11       Impact factor: 1.289

4.  Characterization of leukemias with ETV6-ABL1 fusion.

Authors:  Marketa Zaliova; Anthony V Moorman; Giovanni Cazzaniga; Martin Stanulla; Richard C Harvey; Kathryn G Roberts; Sue L Heatley; Mignon L Loh; Marina Konopleva; I-Ming Chen; Olga Zimmermannova; Claire Schwab; Owen Smith; Marie-Joelle Mozziconacci; Christian Chabannon; Myungshin Kim; J H Frederik Falkenburg; Alice Norton; Karen Marshall; Oskar A Haas; Julia Starkova; Jan Stuchly; Stephen P Hunger; Deborah White; Charles G Mullighan; Cheryl L Willman; Jan Stary; Jan Trka; Jan Zuna
Journal:  Haematologica       Date:  2016-05-26       Impact factor: 9.941

5.  Myeloproliferative neoplasm with ETV6-ABL1 fusion: a case report and literature review.

Authors:  Katya Gancheva; Andres Virchis; Julie Howard-Reeves; Nick Cp Cross; Diana Brazma; Colin Grace; Paul Kotzampaltiris; Fedra Partheniou; Elisabeth Nacheva
Journal:  Mol Cytogenet       Date:  2013-09-20       Impact factor: 2.009

6.  An ETV6-ABL1 fusion in a patient with chronic myeloproliferative neoplasm: Initial response to Imatinib followed by rapid transformation into ALL.

Authors:  Purvi M Kakadia; Ralf Schmidmaier; Andreas Völkl; Irene Schneider; Natalia Huk; Stephanie Schneider; Gerda Panzner; Ulrike Neidel; Barbara Fritz; Karsten Spiekermann; Stefan K Bohlander
Journal:  Leuk Res Rep       Date:  2016-10-14

7.  An activating mutation of GNB1 is associated with resistance to tyrosine kinase inhibitors in ETV6-ABL1-positive leukemia.

Authors:  O Zimmermannova; E Doktorova; J Stuchly; V Kanderova; D Kuzilkova; H Strnad; J Starkova; M Alberich-Jorda; J H F Falkenburg; J Trka; J Petrak; J Zuna; M Zaliova
Journal:  Oncogene       Date:  2017-06-26       Impact factor: 9.867

8.  A novel three-way rearrangement involving ETV6 (12p13) and ABL1 (9q34) with an unknown partner on 3p25 resulting in a possible ETV6-ABL1 fusion in a patient with acute myeloid leukemia: a case report and a review of the literature.

Authors:  Carlos A Tirado; Ken Siangchin; David S Shabsovich; Maryam Sharifian; Gary Schiller
Journal:  Biomark Res       Date:  2016-08-25

Review 9.  New biological and genetic classification and therapeutically relevant categories in childhood B-cell precursor acute lymphoblastic leukemia.

Authors:  Jan Starý; Jan Zuna; Marketa Zaliova
Journal:  F1000Res       Date:  2018-09-28
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.